About this trial
Lifestyle interventions can alleviate Parkinson's Disease (PD) symptoms and delay disease progression. The novelty of this project lies in the development of an innovative smart platform that utilizes artificial intelligence (AI) and predictive models to offer a groundbreaking solution that not only prevents disease progression but also significantly improves the well-being of patients with PD. For this, the technological smart platform will encompass 50 clinical variables, and a comprehensive range of other 50 supplementary variables, validated in a database with more than 1500 patients. The smart platform will include a user-friendly interface with different user profiles and a scalable back end with AI-based monitoring and prediction modules. This will offer primary prevention, early detection, and ongoing monitoring by specialized medical professionals at home and in hospitals.
Eligibility criteria
Qualifiers
Patients with Parkinson's disease
Disqualifiers
N/A
Trial design
Treatments tested in this trial
- Lifestyle intervention
Treatment groups
Sponsors and collaborators
University Ramon Llull
Lead sponsor
University of Deusto
Collaborator
Hospital Universitari Vall d'Hebron Research Institute
Collaborator